|
|
||||||||
Journal of Lipid Research, Vol 36, 1807-1812, Copyright © 1995 by Lipid Research, Inc.
H Gylling, MA Siimes and TA Miettinen
In familial hypercholesterolemia (FH) the lowering of serum cholesterol
levels should be started in childhood in order to prevent coronary artery
disease later in life. However, treatment of children is problematic. We
studied the effects of sitostanol (3 g/day) ester dissolved in rapeseed oil
margarine as a hypocholesterolemic agent in one homozygous and 14
heterozygous children with FH maintained on a low cholesterol diet for 6
weeks, using a double-blind crossover design. Absorption and synthesis of
cholesterol were evaluated by measuring serum plant sterol and cholesterol
precursor proportions to cholesterol by gas-liquid chromatography. The
compliance was good, and the children could not distinguish by taste the
two margarines without and with sitostanol ester. Sitostanol margarine
significantly reduced serum total, intermediate density (IDL), and low
density lipoprotein (LDL) cholesterol by 11, 26, and 15%, respectively, and
increased HDL/LDL cholesterol ratio by 27%. The proportions of serum delta
8-cholestenol, lathosterol, and desmosterol were significantly increased by
36, 19, and 18%, and those of serum cholestanol, campesterol, and
sitosterol were significantly decreased by 9, 42 and 29%, respectively,
suggesting that cholesterol absorption was decreased and synthesis was
compensatorily increased. High basal precursor sterol proportions predicted
a high decrease in LDL cholesterol levels. In conclusion, partial
replacement of normal dietary fat consumption by sitostanol ester margarine
appears to be an effective and safe hypocholesterolemic treatment in
children with FH.
ARTICLES
Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia
Department of Internal Medicine, University of Helsinki, Finland.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Miller, C. Manlhiot, N. Chahal, G. Cullen-Dean, L. Bannister, and B. W. McCrindle Impact of Increasing Adiposity in Hyperlipidemic Children Clinical Pediatrics, September 1, 2008; 47(7): 679 - 684. [Abstract] [PDF] |
||||
![]() |
E. M. Haney, L. H. Huffman, C. Bougatsos, M. Freeman, R. D. Steiner, and H. D. Nelson Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force Pediatrics, July 1, 2007; 120(1): e189 - e214. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. McCrindle, E. M. Urbina, B. A. Dennison, M. S. Jacobson, J. Steinberger, A. P. Rocchini, L. L. Hayman, and S. R. Daniels Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing Circulation, April 10, 2007; 115(14): 1948 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics Circulation, December 12, 2006; 114(24): 2710 - 2738. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Moruisi, W. Oosthuizen, and A. M. Opperman Phytosterols/Stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J. Am. Coll. Nutr., February 1, 2006; 25(1): 41 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A Castro, L. P Barroso, and P. Sinnecker Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach Am. J. Clinical Nutrition, July 1, 2005; 82(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hedman, T. Matikainen, A. Fohr, M. Lappi, S. Piippo, M. Nuutinen, and M. Antikainen Efficacy and Safety of Pravastatin in Children and Adolescents with Heterozygous Familial Hypercholesterolemia: A Prospective Clinical Follow-Up Study J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1942 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Hayes, A. Pronczuk, and D. Perlman Nonesterified Phytosterols Dissolved and Recrystallized in Oil Reduce Plasma Cholesterol in Gerbils and Humans J. Nutr., June 1, 2004; 134(6): 1395 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A Vanstone and P. J. Jones Limitations of plasma plant sterols as indicators of cholesterol absorption Am. J. Clinical Nutrition, February 1, 2004; 79(2): 340 - 341. [Full Text] |
||||
![]() |
References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text] |
||||
![]() |
A. L Amundsen, L. Ose, M. S Nenseter, and F. Y Ntanios Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia Am. J. Clinical Nutrition, August 1, 2002; 76(2): 338 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Hayes, A. Pronczuk, V. Wijendran, and M. Beer Free Phytosterols Effectively Reduce Plasma and Liver Cholesterol in Gerbils Fed Cholesterol J. Nutr., July 1, 2002; 132(7): 1983 - 1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Lichtenstein and R. J. Deckelbaum Stanol/Sterol Ester-Containing Foods and Blood Cholesterol Levels : A Statement for Healthcare Professionals From the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association Circulation, February 27, 2001; 103(8): 1177 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Scientific Statement: AHA Dietary Guidelines: Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association J. Nutr., January 1, 2001; 131(1): 132 - 146. [Full Text] |
||||
![]() |
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association Stroke, November 1, 2000; 31(11): 2751 - 2766. [Full Text] [PDF] |
||||
![]() |
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association Circulation, October 31, 2000; 102(18): 2284 - 2299. [Full Text] [PDF] |
||||
![]() |
T. A. Miettinen, T. E. Strandberg, H. Gylling, and f. t. F. I. o. t. S. S. S. S. Group Noncholesterol Sterols and Cholesterol Lowering by Long-Term Simvastatin Treatment in Coronary Patients : Relation to Basal Serum Cholestanol Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1340 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hallikainen, E. S. Sarkkinen, and M. I. J. Uusitupa Plant Stanol Esters Affect Serum Cholesterol Concentrations of Hypercholesterolemic Men and Women in a Dose-dependent Manner J. Nutr., April 1, 2000; 130(4): 767 - 776. [Abstract] [Full Text] |
||||
![]() |
A. F. Vuorio, H. Gylling, H. Turtola, K. Kontula, P. Ketonen, and T. A. Miettinen Stanol Ester Margarine Alone and With Simvastatin Lowers Serum Cholesterol in Families With Familial Hypercholesterolemia Caused by the FH-North Karelia Mutation Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 500 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Williams, M. C. Bollella, B. A. Strobino, L. Boccia, and L. Campanaro Plant Stanol Ester and Bran Fiber in Childhood: Effects on Lipids, Stool Weight and Stool Frequency in Preschool Children J. Am. Coll. Nutr., December 1, 1999; 18(6): 572 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T. Nguyen The Cholesterol-Lowering Action of Plant Stanol Esters J. Nutr., December 1, 1999; 129(12): 2109 - 2112. [Abstract] [Full Text] |
||||
![]() |
G.R. Thompson Plant lipids that lower serum cholesterol Eur. Heart J., November 1, 1999; 20(21): 1527 - 1529. [PDF] |
||||
![]() |
P. J. Jones, F. Y Ntanios, M. Raeini-Sarjaz, and C. A Vanstone Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men Am. J. Clinical Nutrition, June 1, 1999; 69(6): 1144 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gylling, P. Puska, E. Vartiainen, and T. A. Miettinen Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population J. Lipid Res., April 1, 1999; 40(4): 593 - 600. [Abstract] [Full Text] |
||||
![]() |
M. A Hallikainen and M. I. Uusitupa Effects of 2 low-fat stanol ester–containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects Am. J. Clinical Nutrition, March 1, 1999; 69(3): 403 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Vuorio, H. Turtola, and K. Kontula Neonatal Diagnosis of Familial Hypercholesterolemia in Newborns Born to a Parent With a Molecularly Defined Heterozygous Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3332 - 3337. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |